A new study in Scientific Reports examines this area, looking at how the two are related in low- and middle-income countries (LMIC).
Genentech and Sangamo to develop new therapies
The collaboration focuses on intravenously administered treatments targeting the tau gene, associated with Alzheimer’s disease and other tauopathies. Credit: Milad Fakurian on Unsplash. Sangamo Therapeutics